Last update Aug. 30, 2022
Compatible
We do not have alternatives for Pantoprazole since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Pantoprazole is also known as
Pantoprazole in other languages or writings:
Pantoprazole belongs to this group or family:
Main tradenames from several countries containing Pantoprazole in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by IHAN of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Pantoprazole is a proton pump inhibitor with actions and uses similar to those of omeprazole. Indicated in the treatment of peptic ulcer and gastroesophageal reflux. Oral administration once daily.
It is excreted in breast milk in clinically insignificant amounts (Bor 2017, Plante 2004). Its very high percentage of protein binding explain the negligible passage into breast milk observed.
Non-acid-fast forms of pantoprazole are destroyed in the stomach. Since it's neutralized by the acid pH of stomach, capsules with enteric coated granules are used. Because of this, it is thought that the small quantity of Pantoprazole that may reach the breast milk would be neutralized by infant's stomach. In addition, absorption is greatly decreased by the presence of food.
It can cause gynecomastia, galactorrhea and hyperprolactinemia. (Ashfaq 2022)
Several medical societies and expert authors consider the use of this medication possible during breastfeeding. (Hale, LactMed, Briggs 2015, Schaefer 2015, Rowe 2013, Nava 2006)